These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11437953)

  • 1. Tritiated photoactivatable analogs of the native human thrombin receptor (PAR-1) agonist peptide, SFLLRN-NH2.
    Elliott JT; Hoekstra WJ; Derian CK; Addo MF; Maryanoff BE; Ahern DG; Prestwich GD
    J Pept Res; 2001 Jun; 57(6):494-506. PubMed ID: 11437953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoactivatable peptides based on BMS-197525: a potent antagonist of the human thrombin receptor (PAR-1).
    Elliott JT; Hoekstra WJ; Maryanoff BE; Prestwich GD
    Bioorg Med Chem Lett; 1999 Jan; 9(2):279-84. PubMed ID: 10021945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs.
    Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ
    Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin receptor-activating peptides (TRAPs): investigation of bioactive conformations via structure-activity, spectroscopic, and computational studies.
    Ceruso MA; McComsey DF; Leo GC; Andrade-Gordon P; Addo MF; Scarborough RM; Oksenberg D; Maryanoff BE
    Bioorg Med Chem; 1999 Nov; 7(11):2353-71. PubMed ID: 10632045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ligand binding regions of the Saccharomyces cerevisiae alpha-factor pheromone receptor by photoaffinity cross-linking.
    Son CD; Sargsyan H; Naider F; Becker JM
    Biochemistry; 2004 Oct; 43(41):13193-203. PubMed ID: 15476413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptor-2 (PAR-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes.
    Maryanoff BE; Santulli RJ; McComsey DF; Hoekstra WJ; Hoey K; Smith CE; Addo M; Darrow AL; Andrade-Gordon P
    Arch Biochem Biophys; 2001 Feb; 386(2):195-204. PubMed ID: 11368342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin receptor (PAR-1) antagonists. Heterocycle-based peptidomimetics of the SFLLR agonist motif.
    Hoekstra WJ; Hulshizer BL; McComsey DF; Andrade-Gordon P; Kauffman JA; Addo MF; Oksenberg D; Scarborough RM; Maryanoff BE
    Bioorg Med Chem Lett; 1998 Jul; 8(13):1649-54. PubMed ID: 9873407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrocyclic hexapeptide analogues of the thrombin receptor (PAR-1) activation motif SFLLRN.
    McComsey DF; Hecker LR; Andrade-Gordon P; Addo MF; Maryanoff BE
    Bioorg Med Chem Lett; 1999 Jan; 9(2):255-60. PubMed ID: 10021940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species variability in platelet and other cellular responsiveness to thrombin receptor-derived peptides.
    Connolly TM; Condra C; Feng DM; Cook JJ; Stranieri MT; Reilly CF; Nutt RF; Gould RJ
    Thromb Haemost; 1994 Oct; 72(4):627-33. PubMed ID: 7878643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular requirements involving the human platelet protease-activated receptor-4 mechanism of activation by peptide analogues of its tethered-ligand.
    Moschonas IC; Kellici TF; Mavromoustakos T; Stathopoulos P; Tsikaris V; Magafa V; Tzakos AG; Tselepis AD
    Platelets; 2017 Dec; 28(8):812-821. PubMed ID: 28267389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation.
    Coller BS; Springer KT; Scudder LE; Kutok JL; Ceruso M; Prestwich GD
    J Biol Chem; 1993 Oct; 268(28):20741-3. PubMed ID: 8104935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indications for the presence of an atypical protease-activated receptor on rat platelets.
    Ruef J; Kacharava A; Pohl J; Bode C; Runge MS
    Ann Hematol; 2000 Nov; 79(11):604-11. PubMed ID: 11131919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1).
    McComsey DF; Hawkins MJ; Andrade-Gordon P; Addo MF; Oksenberg D; Maryanoff BE
    Bioorg Med Chem Lett; 1999 May; 9(10):1423-8. PubMed ID: 10360749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1).
    Nantermet PG; Barrow JC; Lundell GF; Pellicore JM; Rittle KE; Young M; Freidinger RM; Connolly TM; Condra C; Karczewski J; Bednar RA; Gaul SL; Gould RJ; Prendergast K; Selnick HG
    Bioorg Med Chem Lett; 2002 Feb; 12(3):319-23. PubMed ID: 11814787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of chemotactic peptide analogs with a photoaffinity cross-linker as new probes for analysis of receptor-ligand interaction.
    Shibue M; Yoshiki M; Miyazaki M; Fujita I; Osada S; Yasuda S; Nakamura H; Hamasaki Y; Kondo M; Maeda H; Kodama H; Shimizu H
    Protein Pept Lett; 2003 Apr; 10(2):147-53. PubMed ID: 12678812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Conotoxin GI benzoylphenylalanine derivatives. (1)H-NMR structures and photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor.
    Kasheverov IE; Chiara DC; Zhmak MN; Maslennikov IV; Pashkov VS; Arseniev AS; Utkin YN; Cohen JB; Tsetlin VI
    FEBS J; 2006 Apr; 273(7):1373-88. PubMed ID: 16689926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early intraplatelet signaling enhances the release of human platelet PAR-1 and -4 amino-terminal peptides in response to thrombin.
    Ofosu FA; Dewar L; Song Y; Cedrone AC; Hortelano G; Craven SJ
    Biochemistry; 2009 Feb; 48(7):1562-72. PubMed ID: 19182900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand.
    Hammes SR; Coughlin SR
    Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease.
    Kinlough-Rathbone RL; Perry DW; Packham MA
    Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.